Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021” Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab Clinical and Molecular Hepatology.2025; 31(2): e200. CrossRef
Non-alcoholic fatty liver disease (NAFLD) is accepted as a counterpart to alcohol-related liver disease because it is defined as hepatic steatosis without excessive use of alcohol. However, the definition of moderate alcohol consumption, as well as whether moderate alcohol consumption is beneficial or detrimental, remains controversial. In this review, the findings of clinical studies to date with high-quality evidence regarding the effects of moderate alcohol consumption in NAFLD patients were compared and summarized.
Citations
Citations to this article as recorded by
Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung Journal of Korean Medical Science.2026;[Epub] CrossRef
Effects of moderate beer consumption on immunity and the gut microbiome in immunosuppressed mice Shumin HU, Hua YIN, Xiaxia LI, Minghao FAN, Huajun LI Bioscience of Microbiota, Food and Health.2025; 44(1): 32. CrossRef
Changes in drinking levels and metabolic dysfunction-associated steatotic liver disease: a longitudinal study from the China multi-ethnic cohort study Ning Zhang, Jingzhong Li, Xiaofen Xie, Yifan Hu, Hongxiang Chen, Yuan Zhang, Yujie Liu, Xingren Zhu, Hao Xu, Zhenghong Wang, Kangzhuo Baima, Xuehui Zhang, Zixiu Qin, Zhimiao Yu, Xiong Xiao, Xing Zhao BMC Public Health.2025;[Epub] CrossRef
Alcohol-associated liver disease: Natural history, management and novel targeted therapies Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós-Ginès, Ana Clemente-Sánchez, Hugo López-Pelayo, Ramón Bataller Clinical and Molecular Hepatology.2025; 31(Suppl): S112. CrossRef
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo International Journal of Molecular Sciences.2025; 26(4): 1778. CrossRef
Association between alcohol consumption and hepatic fibrosis in Chinese adult males with metabolic dysfunction-associated steatotic liver disease Mao Li, Bin Yu, Xiaoli Zhang, Jia Pan, Lei Tang, Yi Zhang, Ruixin Wang, Honglian Zeng, Shujuan Yang Frontiers in Medicine.2025;[Epub] CrossRef
Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond Eva Juárez-Hernández, Montserrat Berrospe-Alfaro, Misael Uribe, Iván López-Mendez Journal of Clinical and Experimental Hepatology.2025; 15(6): 103114. CrossRef
Alcohol-Induced Oxidative Stress and Gut–Liver–Brain Crosstalk: Expanding the Paradigm from ALD to MetALD Jeong-Yoon Lee, Young-Min Jee, Keungmo Yang, Tom Ryu Antioxidants.2025; 14(10): 1196. CrossRef
Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung Annals of Liver Transplantation.2025; 5(2): 107. CrossRef
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn Liver Cancer.2024; 13(5): 561. CrossRef
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1599. CrossRef
Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies Naouras Bouajila, Cloé Domenighetti, Henri-Jean Aubin, Mickael Naassila Frontiers in Epidemiology.2024;[Epub] CrossRef
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease Ji-Won Park, Ki Tae Suk Clinical and Molecular Hepatology.2023; 29(2): 408. CrossRef
Oxidative balance score is inversely associated with the incidence of non-alcoholic fatty liver disease A-Ra Cho, Yu-Jin Kwon, Jun-Hyuk Lee Clinical Nutrition.2023; 42(8): 1292. CrossRef
Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank Yu Jia, Dongze Li, Yi You, Jing Yu, Wenli Jiang, Yi Liu, Rui Zeng, Zhi Wan, Yi Lei, Xiaoyang Liao BMC Medicine.2023;[Epub] CrossRef
Alcohol consumption and the risk of liver disease: a nationwide, population-based study Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek Frontiers in Medicine.2023;[Epub] CrossRef
Anemia appears frequently in patients with alcoholic liver disease (ALD) but has never been linked to bilateral nonarteritic anterior ischemic optic neuropathy (NAION). A 65-year-old woman with a medical history of alcoholic cirrhosis was admitted for bilateral NAION. On admission, she was found to have a low arterial pressure and severe normocytic anemia (48 g/L). The anemia was related to chronic bleeding due to antral gastritis along with other factors associated with ALD. The applied treatment consisted of urgent transfusion followed by high doses of proton-pump inhibitors, iron and vitamin supplementation, and support in lifestyle measures. Her hemoglobin levels remained stable after 2 years but the patient still suffered from visual loss. This case highlights the link between anemia and bilateral NAION in ALD patients. The optic nerve head is prone to infarction in this context due to the vascularization characteristics of ALD. Hemoglobin levels should be monitored in ALD patients to avoid the severe complication of NAION.
Citations
Citations to this article as recorded by
Bilateral Optic Disc Swelling with Persistent Visual Loss in Anemia: Case Report Kim Van Langenhove, Marcel Paulus Maria Ten Tusscher Case Reports in Ophthalmology.2023; : 535. CrossRef
Analysis of Systemic Risk Factors and Post-Insult Visual Development in a Danish Cohort of Patients with Nonarteritic Anterior Ischemic Optic Neuropathy Gülsenay Citirak, Lasse Malmqvist, Steffen Hamann Clinical Ophthalmology.2022; Volume 16: 3415. CrossRef
Hyperhomocysteinemia and low folate levels as the only risk factors in pseudo-Foster Kennedy syndrome M. Rahhal-Ortuño, A.S. Fernández-Santodomingo, E. Marín-Payá, M. Aguilar-González, C.K. Villena-Alvarado, L. Ramos-González Journal Français d'Ophtalmologie.2021; 44(6): e353. CrossRef
Ischemic Optic Neuropathy Caused by Iron Deficiency Anemia Accompanied by Ethambutol-induced Toxic Optic Neuropathy Li Lyung Wang, Hee Jun Song, Young Hee Jung, Ju-Yeun Lee Journal of the Korean Ophthalmological Society.2020; 61(11): 1399. CrossRef
First
Prev
